Next |
home / stock / acor / acor message board
Subject | By | Source | When |
---|---|---|---|
MomentumIts now up | cash4 | investorshub | 06/23/2023 1:37:51 PM |
Price gaining | Upgrader | investorshub | 06/23/2023 4:16:48 AM |
$ACOR The trading | BoilerRoom | investorshub | 06/22/2023 2:18:13 PM |
$ACOR must see | cash4 | investorshub | 06/22/2023 12:21:19 PM |
$ACOR must see | Invest-in-America | investorshub | 06/19/2023 10:16:38 PM |
bulls and bears | Mt. Blanc | investorshub | 06/19/2023 3:10:01 AM |
$ACOR Looks pretty positive | blitz999 | investorshub | 06/18/2023 3:37:00 AM |
The trading | barnyarddog | investorshub | 06/17/2023 4:40:09 AM |
are we finally gonna see some action | crudeoil24 | investorshub | 06/16/2023 6:59:41 PM |
MomentumIts now last up | 81vette | investorshub | 06/16/2023 4:24:43 AM |
$ACOR MomentumIts now last up | cash4 | investorshub | 06/16/2023 2:02:37 AM |
MomentumIts trading last trade up | DK11 | investorshub | 06/12/2023 2:52:18 PM |
$ACOR The trading up | BoilerRoom | investorshub | 06/11/2023 1:19:52 AM |
we got news | Invest-in-America | investorshub | 06/09/2023 8:15:43 PM |
$ACOR The trading up | cash4 | investorshub | 06/09/2023 1:37:48 PM |
$ACOR What do you make of this? | INFINITI | investorshub | 06/07/2023 1:41:53 PM |
must see | everton44 | investorshub | 06/05/2023 9:04:19 AM |
$ACOR oh yeah news for the day | everton44 | investorshub | 06/05/2023 6:55:01 AM |
$ACOR MomentumIts now up | subslover | investorshub | 06/03/2023 7:09:45 AM |
$ACOR Price now last up | Actualfactual | investorshub | 05/31/2023 10:11:17 AM |
News, Short Squeeze, Breakout and More Instantly...
Acorda Therapeutics Inc. Company Name:
ACOR Stock Symbol:
NASDAQ Market:
Acorda Therapeutics Inc. Website:
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business on April 12, 2024. The notice follows the Company's April 1, 2024 announc...
Acorda Files for Voluntary Chapter 11 Protection to Facilitate Orderly Sale Acorda Enters into a Restructuring Support Agreement with over 90% of the Secured Convertible Noteholders Patient Access to INBRIJA ® (levodopa inhalation powder) and AMPYRA ® (...
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will no longer hold its fourth quarter and year end 2023 earnings conference call originally scheduled for Monday, April 1 at 4:30 p.m. ET. The Company does expect to timely file its Annual Report on Form 10-K for the period ended D...